Single EV analysis (sEVA) of mutated proteins allows detection of stage 1 pancreatic cancer
Preprint
Abstract
Tumor cell derived extracellular vesicles (EV) are being explored as circulating biomarkers for cancer detection. Up to now however, clinical results have been mixed for a number of reasons including the predominant use of bulk measurements, the inability to differentiate tumor from host cell derived vesicles, the general absence of uniquely identifying biomarkers and the unknown frequency of stochastically distributed biomarkers into single circulating vesicles. We hypothesized that a single EV analysis (sEVA) technique could potentially improve diagnostic accuracy necessary to detect early cancers but the actual biomarker frequency and practical detection limits are currently unknown. Using pancreatic cancer, we carefully analyzed the composition of putative cancer markers in 11 established and new patient derived models. In parental PDAC cells positive for KRAS mut and/or P53 mut proteins only ∼40% of EVs were also positive (range: 30-64%). This rate of positivity increased to 57% when additional PDAC biomarkers were considered (MUC1, EGFR, ⍺FG-P4OH) in cell lines. In a blinded study involving 16 patients with surgically proven stage 1 PDAC, KRAS mut and P53 mut protein was detectable at much lower levels, generally in < 0.1% of vesicles. With the analytical capabilities of sEVA however, 15 of the 16 patients with stage 1 PDAC expressed low levels of biomarker positive EV. Using a modeling approach, we estimate that the current PDAC detection limit is at ∼0.1 cm 3 tumor volume, below clinical imaging capabilities. These findings establish the potential for single-EV analysis for early cancer detection.Keywords
All Related Versions
- Published version: Science Advances, 8 (16), eabm3453.
This publication has 65 references indexed in Scilit:
- Miniature magnetic resonance system for point-of-care diagnosticsLab on a Chip, 2011
- Phenotype and Genotype of Pancreatic Cancer Cell LinesPancreas, 2010
- Prolyl 4-Hydroxylation of α-FibrinogenJournal of Biological Chemistry, 2009
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic CancerScience, 2009
- Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null miceCell Death & Differentiation, 2008
- Chip–NMR biosensor for detection and molecular analysis of cellsNature Medicine, 2008
- Divergent Roles for RalA and RalB in Malignant Growth of Human Pancreatic Carcinoma CellsCurrent Biology, 2006
- Both p16 Ink4a and the p19 Arf -p53 pathway constrain progression of pancreatic adenocarcinoma in the mouseProceedings of the National Academy of Sciences, 2006
- Pancreatic Cancer Proteome: The Proteins That Underlie Invasion, Metastasis, and Immunologic EscapeGastroenterology, 2005
- Activation of RalA is critical for Ras-induced tumorigenesis of human cellsCancer Cell, 2005